Skip to main content
Equibles

Angela Cacace

Arvinas, Inc. (ARVN)

Equibles does not estimate personal net worth.

Get an email with a short summary when Arvinas, Inc. publishes a filing, an earnings call transcript or a press release.

Get ARVN alerts

About Angela Cacace

The proxy statement of Arvinas, Inc. reports total compensation of $3,300,914 for Angela Cacace in fiscal 2025, including a base salary of $500,763. Disclosed compensation is on record for 2 fiscal years. Angela Cacace has spoken on 1 earnings call across 1 company, most recently for Arvinas, Inc. on August 4, 2026. Arvinas, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Arvinas, Inc. includes Randy Teel, Ph.D. (CEO and Board Member), Briggs Morrison, M.D. (Chairman), Randy Teel (CFO) and 7 others.

Angela Cacace on recent calls

“The Arvinas approach to breakthrough medicine begins with choosing the right biology. The most important decision is selecting targets where targeted protein degradation can fundamentally change the course of disease.”
Other, Arvinas, Inc. Q2 FY2026 Earnings Call ·

Affiliation history

Company network

Leadership on record at Arvinas, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Arvinas, Inc. (ARVN) $500,763 $3,300,914
2024 Arvinas, Inc. (ARVN) $464,753 $2,972,309

Recent activity